BACKGROUND: Chronic obstructive pulmonary disease (COPD) is associated with higher mortality in the general population. We studied the associations between COPD and death among chronic kidney disease (CKD) patients along with reporting cause-specific death data. METHODS: We included 56,960 patients with stages 3 and 4 CKD who were followed in a large health care system. Associations between COPD and all-cause mortality and various causes of death (respiratory deaths, cardiovascular deaths, malignancy-related deaths and deaths due to other reasons) were studied using the Cox proportional hazards and competing risk models. RESULTS: Out of 56,960 CKD patients, 4.7% (n = 2,667) had underlying COPD. Old age, presence of diabetes, hypertension, coronary artery disease, congestive heart failure, and smoking were associated with higher risk for COPD. During a median follow-up of 3.7 years, 15,969 patients died. After covariate adjustment, COPD was associated with a 41% increased risk (95% CI 1.31-1.52) for all-cause mortality, and fourfold increased risk (sub-hazard ratio 4.36, 95% CI 3.54-5.37) for respiratory-related deaths. In a sensitivity analysis that was performed by defining COPD as the use of relevant International Classification of Diseases-9 codes and medications used to treat COPD, similar results were noted. CONCLUSIONS: COPD is associated with higher risk for death among those with CKD, and an underlying lung disease accounts for significant proportion of deaths. These data highlight the need for further prospective studies to understand the underlying mechanisms and potential interventions to improve outcomes in this population.
BACKGROUND:Chronic obstructive pulmonary disease (COPD) is associated with higher mortality in the general population. We studied the associations between COPD and death among chronic kidney disease (CKD) patients along with reporting cause-specific death data. METHODS: We included 56,960 patients with stages 3 and 4 CKD who were followed in a large health care system. Associations between COPD and all-cause mortality and various causes of death (respiratory deaths, cardiovascular deaths, malignancy-related deaths and deaths due to other reasons) were studied using the Cox proportional hazards and competing risk models. RESULTS: Out of 56,960 CKDpatients, 4.7% (n = 2,667) had underlying COPD. Old age, presence of diabetes, hypertension, coronary artery disease, congestive heart failure, and smoking were associated with higher risk for COPD. During a median follow-up of 3.7 years, 15,969 patients died. After covariate adjustment, COPD was associated with a 41% increased risk (95% CI 1.31-1.52) for all-cause mortality, and fourfold increased risk (sub-hazard ratio 4.36, 95% CI 3.54-5.37) for respiratory-related deaths. In a sensitivity analysis that was performed by defining COPD as the use of relevant International Classification of Diseases-9 codes and medications used to treat COPD, similar results were noted. CONCLUSIONS:COPD is associated with higher risk for death among those with CKD, and an underlying lung disease accounts for significant proportion of deaths. These data highlight the need for further prospective studies to understand the underlying mechanisms and potential interventions to improve outcomes in this population.
Authors: Jayanta Gupta; Nandita Mitra; Peter A Kanetsky; Joe Devaney; Maria R Wing; Muredach Reilly; Vallabh O Shah; Vaidyanathapura S Balakrishnan; Nicolas J Guzman; Matthias Girndt; Brian G Periera; Harold I Feldman; John W Kusek; Marshall M Joffe; Dominic S Raj Journal: Clin J Am Soc Nephrol Date: 2012-09-27 Impact factor: 8.237
Authors: Sankar D Navaneethan; Jesse D Schold; John P Kirwan; Susana Arrigain; Stacey E Jolly; Emilio D Poggio; Srinivasan Beddhu; Joseph V Nally Journal: Clin J Am Soc Nephrol Date: 2013-02-14 Impact factor: 8.237
Authors: Divay Chandra; Jason A Stamm; Paul M Palevsky; Joseph K Leader; Carl R Fuhrman; Yingze Zhang; Jessica Bon; Steven R Duncan; Robert A Branch; Joel Weissfeld; David Gur; Mark T Gladwin; Frank C Sciurba Journal: Chest Date: 2012-09 Impact factor: 9.410
Authors: Michael J Abramson; Rosa L Schattner; Nabil D Sulaiman; Eleonora A Del Colle; Rosalie Aroni; Francis Thien Journal: Prim Care Respir J Date: 2012-06
Authors: Linda Leivseth; Ben Michael Brumpton; Tom Ivar Lund Nilsen; Xiao-Mei Mai; Roar Johnsen; Arnulf Langhammer Journal: Thorax Date: 2013-04-23 Impact factor: 9.139
Authors: Jennifer K Quint; Hana Müllerova; Rachael L DiSantostefano; Harriet Forbes; Susan Eaton; John R Hurst; Kourtney Davis; Liam Smeeth Journal: BMJ Open Date: 2014-07-23 Impact factor: 2.692
Authors: Danielle L Kirkman; Natalie Bohmke; Salvatore Carbone; Ryan S Garten; Paula Rodriguez-Miguelez; Robert L Franco; Jason M Kidd; Antonio Abbate Journal: Am J Physiol Renal Physiol Date: 2020-12-07
Authors: Richard V Remigio; Chengsheng Jiang; Jochen Raimann; Peter Kotanko; Len Usvyat; Frank W Maddux; Patrick Kinney; Amir Sapkota Journal: JAMA Netw Open Date: 2019-08-02
Authors: Leah Hernandez; Agne Laucyte-Cibulskiene; Liam J Ward; Alexandra Kautzky-Willer; Maria-Trinidad Herrero; Colleen M Norris; Valeria Raparelli; Louise Pilote; Peter Stenvinkel; Karolina Kublickiene Journal: Front Cardiovasc Med Date: 2022-08-08